W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Position of the Transparency Council

Position of the Transparency Council – Kuvan (sapropterin)

more...

Position of the Transparency Council – Ultomiris (ravulizumab)

more...

Position of the Transparency Council – Omvoh (mirikizumab)

more...

Position of the Transparency Council – Zolgensma (onasemnogene abeparvovec)

more...

Position of the Transparency Council – Ayvakyt (avapritinib)

more...

Position of the Transparency Council – Daraprim

more...

Position of the Transparency Council – on the validity of the qualification of the service Gyroscopic Stereotactic Teleradiotherapy (TSZ) using the novel ZAP-X device

more...

Position of the Transparency Council – Cablivi (caplacizumab)

more...

Position of the Transparency Council – Ilaris (canakinumab)

more...

Position of the Transparency Council – Tecentriq (atezolizumab)

more...

Position of the Transparency Council – Fintepla (fenfluramine)

more...

Position of the Transparency Council – Agamree (vamorolone)

more...

Position of the Transparency Council – Agamree (vamorolone)

more...

Position of the Transparency Council – Lynparza (olaparib)

more...

Position of the Transparency Council – Hemlibra (emicizumab)

more...

Position of the Transparency Council – Opdivo (nivolumab)

more...

Position of the Transparency Council – Cabometyx (cabozantinib)

more...

Position of the Transparency Council – Glycosade

more...

Position of the Transparency Council – Keytruda (pembrolizumab)

more...

Position of the Transparency Council – Kanuma (sebelipase alfa)

more...

Position of the Transparency Council – Prophylaxis of necrotizing enterocolitis (NEC) in premature infants with birth weight less than 1,500 g using a food for special medical use, a three-strain probiotic product that meets the criteria of the ESPGHAN recommendation

more...

Position of the Transparency Council – Zynlonta (lonkastuximab thesirine)

more...

Position of the Transparency Council – Acarizax

more...

Position of the Transparency Council – on the appropriateness of issuing approvals for reimbursement of foodstuffs Foodstuffs for special nutritional use S.O.S. 10, S.O.S. 15, S.O.S. 20, S.O.S. 25

more...